Marker Therapeutics

Developer of T-cell based therapeutics for cancer treatment

placeHouston, Texas, United States calendar_todayFounded 1991 groups67 employees language markertherapeutics.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace steady. Cited 4 times.

YearFilings
20221
20231
20242

Social engagement

Social engagement: 4.8K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital222%
Private equity111%
Other / undisclosed667%

Recent activity

26 Jan 2026
Milestone
regulatory
26 Nov 2025
Event
ASH25
5 Nov 2025
Leadership hire
Board of Directors
Coming soon